Mounjaro
Eli Lilly Expands Manufacturing to Meet Mounjaro Demand Surge
Eli Lilly’s diabetes medication Mounjaro has continued to experience robust sales growth despite supply challenges, with the GLP-1/GIP agonist generating ...
Eli Lilly sues fake Mounjaro sellers for trademark infringement and false advertising
Eli Lilly, the pharmaceutical giant, is intensifying its legal efforts to combat unauthorized versions of its popular diabetes drug, Mounjaro. ...
FDA warns companies selling unauthorized obesity drugs similar to Wegovy and Mounjaro
The soaring demand for new anti-obesity medications has led to a concerning trend, with various online companies attempting to sell ...
Eli Lilly Reshuffles C-Suite Leadership Amid Crucial Mounjaro Decision Looming
Eli Lilly is undergoing leadership changes in its diabetes and obesity division as it anticipates a significant FDA decision in ...
Eli Lilly Sues 8 Companies for selling fake Mounjaro versions
The surging demand for GLP-1 diabetes and weight loss medications has led to an inevitable influx of knockoff versions. Earlier ...
Eli Lilly’s Mounjaro gets NICE approval for type 2 diabetes after cost-effectiveness review
Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), has been on a winning streak since its US launch in May, and now ...
Novo Nordisk and Eli Lilly Ride Obesity and Diabetes Drugs to the Forefront in Q2 Pharmaceutical Performance
As the COVID-19 pandemic surged and waned, the biopharmaceutical industry witnessed a rollercoaster ride of revenue spikes and troughs. However, ...
How Mounjaro Boosted Eli Lilly’s Sales and Fought Obesity
As Eli Lilly’s flagship diabetes medication, Mounjaro, continues its meteoric rise in popularity and edges closer to potential approval for ...
Eli Lilly’s Tirzepatide Succeeds in 2 More Late-Stage Obesity Trials Ahead of FDA Decision
Source – Eli Lilly Eli Lilly continues to gather strong evidence supporting the effectiveness of tirzepatide, its dual GIP/GLP-1 agonist, ...
National Institute for Health and Care Excellence remains skeptical about the effectiveness of Mounjaro for diabetes
Eli Lilly has received positive data for its experimental obesity therapies, but in the UK, it faced a setback as ...
Weight-Loss Medications Market Projected to Reach $60 Billion in 10 Years
According to a Morningstar analyst, frantic demand for pharmaceuticals to treat obesity from Novo Nordisk, Eli Lilly, and other companies ...
